Blood test for glutathione peroxidase 4 in ankylosing spondylitis and psoriatic arthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study measures a protein in the blood called glutathione peroxidase 4 (GPX4) in people with ankylosing spondylitis or psoriatic arthritis. The goal is to see if GPX4 levels differ in these conditions, which might help with diagnosis or treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with ankylosing spondylitis or psoriatic arthritis by your doctor.
- You do not have other autoimmune rheumatic diseases (like lupus or rheumatoid arthritis).
- You do not have severe liver or kidney problems, blood disorders, infections, tumors, or other serious wasting conditions.
- You are not taking certain medications like sulfasalazine, artemisinin, statins, or experimental drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the levels of a specific enzyme (15-hydroxyprostaglandin dehydrogenase) in the blood and joints of people with osteoarthritis or ankylosing spondylitis. The goal is to see if this enzyme can help tell these conditions apart or show how active they are.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at how a gluten-free diet affects people with ankylosing spondylitis (a type of arthritis that mainly affects the spine). You would eat no gluten (found in wheat, barley, and rye) for a period of time to see if it helps reduce symptoms.
This study uses a blood test called mass spectrometry to look at the immune system in people with active autoimmune diseases. It aims to find patterns that could help doctors better understand and treat these conditions.
This study looks at a specific gene (TNFAIP3) that may affect inflammation in two types of arthritis: ankylosing spondylitis (which affects the spine) and psoriatic arthritis (which often comes with psoriasis). The goal is to see if this gene relates to how active the disease is, which might help understand these conditions better.
This study compares liver health (including liver ultrasound and blood test results) in people with psoriatic arthritis who have been treated with different biologic medicines or methotrexate for at least 2 years. The goal is to see if one treatment may be more protective for the liver than others.
Hear when a new Spondyloarthropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.